ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics, [S. l.], v. 73, p. e1err, 2018. DOI: 10.6061/clinics/2018/e1err. Disponível em: https://revistas.usp.br/clinics/article/view/144536.. Acesso em: 7 may. 2024.